Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes
Hiroyuki Ito1, Suzuko Matsumoto1, Takuma Izutsu1, Eiji Kusano1, Shinya Nishio1, Shinichi Antoku1, Tomoko Yamasaki1, Toshiko Mori1, Michiko Togane1, Shigenori Ando2, Emiko Tsugami2 1Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan; 2Department of Pharmacy, Edogawa...
Enregistré dans:
Auteurs principaux: | Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7e54d61ca04c47f7b4ed52d9054601d6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
par: Santos Cavaiola T, et autres
Publié: (2018) -
Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)
par: K. Tobe, et autres
Publié: (2021) -
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
par: Munir KM, et autres
Publié: (2016) -
Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
par: David Bobrowski, et autres
Publié: (2021) -
Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
par: Fan Yang, et autres
Publié: (2020)